Pfizer is asking U.S. regulators to authorize its updated COVID-19 vaccine for children under age 5 - not as a booster but part of their initial three dose vaccine regimen.
Daily review is also your post. This provides Standardistas the opportunity to review events of the day. The usual rules of good behaviour apply (see the Policy). Don’t forget to be kind to each other …